We Study Billionaires
We Study Billionaires

TIP 105 : Mastermind Group 2016 3rd Quarter (Business Podcast)

IN THIS EPISODE, YOU’LL LEARN: How can an investor find a decent yield when many asset classes are overvalued. Why special situations might be the best investing approach right now. If Humana is a profitable risk arbitrage bet right now. How you can generate a steady cash flow by selling put options

Featured Speakers

Stig Brodersen Host

Topics Discussed

Episode Summary

Executive Summary: The mastermind discussion focused on how investors should navigate a low- or negative-rate world, using special situations like merger arbitrage, options selling, and deep-value stock selection as examples. The group debated insurance companies, real estate, QE, and market valuation, ultimately stressing disciplined risk management, skepticism toward easy narratives, and the need for independent analysis rather than blind index investing or media-driven views.

Main Topics: Investing in a low-rate, overvalued market (Priority: 5/5): Hari frames the problem of distorted prices, unattractive yields, and few obvious opportunities, prompting the group to discuss what retail investors should do when traditional asset classes look expensive or impaired. Special situations and merger arbitrage (Priority: 5/5): Toby explains risk arbitrage using Humana/Aetna as the example, emphasizing that the trade is based on the gap between current price and deal value, but with real uncertainty about whether the transaction closes. Insurance companies under zero-rate conditions (Priority: 5/5): The group debates how low rates affect insurers like Berkshire and whether rising rates would hurt float and bond portfolios. They note that insurer balance sheets and duration matching matter a lot in valuation and risk assessment. Real estate, leverage, and rate sensitivity (Priority: 4/5): Preston argues that high-end real estate may be vulnerable if rates rise, while leveraged property may behave differently. The discussion highlights that commercial or rental real estate may be more resilient than luxury housing. Options selling as a return strategy (Priority: 4/5): Toby describes selling puts on cheap, volatile stocks as a way to generate attractive annualized returns, essentially underwriting equity exposure with a time-based premium and a safety buffer. Dollar-cost averaging and market timing skepticism (Priority: 4/5): Colin asks whether dollar-cost averaging still makes sense. Preston and others argue the market is expensive and defensive positioning is rational, but they still favor sticking to a plan over emotional timing. QE, central banks, and asset prices (Priority: 4/5): The panel debates whether quantitative easing causes stock-market gains or merely coincides with them. They also discuss whether low rates support government debt sustainability and whether prolonged easing could weaken confidence in the dollar.

Key Arguments: In overvalued markets, investors should look for special situations and deep-value opportunities rather than broad market exposure. Risk arbitrage is not true arbitrage; it carries real deal-closing risk, so investors must assess downside if the merger fails. A target like Humana can still be attractive because it has intrinsic value, cash, and a history of share buybacks that could support price if the deal breaks. Insurance investing depends heavily on balance-sheet structure and duration matching; different insurers face different interest-rate risks. High-end real estate may be especially vulnerable to rising rates, while leveraged or income-producing property could be more resilient. Selling put options on cheap, volatile stocks can produce strong annualized returns if the investor is already willing to own the shares. Dollar-cost averaging can still be sensible as a long-term discipline, but in expensive markets investors should remain cautious and protect downside risk. QE may be more psychologically than mechanically market-supportive, and its relationship to asset prices is debated rather than settled. Low interest rates help governments finance debt more cheaply, but long-term persistence may erode confidence in fiat currency and support alternatives like gold. The recurring theme across all topics is that investors must do their own analysis instead of relying on media narratives or simple rules. Cash, despite feeling unproductive, is often a rational defensive posture when valuations are elevated and yields are scarce.

Data Points: Episode number: 105 - The Investors Podcast episode identifier Date referenced: 12 September 2016 - Recording date mentioned in the intro Berkshire Hathaway cash and cash equivalents: $72.6 billion - Preston cites Berkshire’s balance sheet while discussing the impact of low rates Humana market capitalization: $26 billion - Toby describes Humana as a large-cap special situation Humana share price: $175–$180 - Approximate trading range discussed during the merger arbitrage example Humana bid price: $225 - Aetna’s offer value referenced in the merger discussion Humana cash component of bid: $125 cash + 0.8375 Aetna shares - Details of the acquisition consideration Humana acquisition spread: About $50 per share - Difference between current price and bid value at roughly $175 Humana/Acquirers Multiple: Less than 9x - Toby says Humana screens cheap on the Acquirers Multiple website Risk arb historical return: ~20% compound per annum - Toby cites Buffett’s long-run average return from merger/risk arbitrage Target annualized return on options trades: 35%–40%+ - Toby’s threshold for selling puts in crisis situations Lower threshold for option proxy trades: ~25% - When the goal is mainly to acquire stock cheaper rather than maximize option income SP 500 dividend yield: About 2% - Preston and Stig discuss index returns being mainly dividend-driven DOW level change over 5 years: Basically unchanged - Preston claims the Dow had not materially moved since the show started Shiller P/E reference: 44x - Preston mentions the 2000 market level as a cautionary benchmark Potential Shiller-based market level: Around 3,000 - Preston’s estimate of where the market could go if valuations normalized to 2000 levels QE3 sequencing: ECB took over after U.S. Fed wound down QE3 in Nov. 2014 - Preston uses this to argue central bank easing may be globally coordinated Debt sensitivity: Interest-rate increases of 1% can materially raise debt service - Hari argues low rates keep government financing costs lower Option timing horizon: 3, 6, 9, or 18 months - Toby prefers whichever expiry gives the best annualized return

Pivotal Quotes: "This is risk arbitrage. And so, risk arbitrage is not a true arbitrage." — Toby Carlau: Clarifying that merger-related trades involve real uncertainty, not guaranteed profit "I can tell you all the reasons why this market's really expensive and why this bull market's really long in the tooth." — Preston Pisch: Summarizing the panel’s bearish view on broad market valuations "What starts as a simple self-custody now involves family legacy planning, sophisticated security decisions, and navigating situations where a single mistake could cost generations of wealth." — Sponsor read: Unchained Signature ad read highlighting complexity for long-term Bitcoin holders

Implications: Listeners are urged to stay disciplined in expensive, low-yield markets, favoring cash, special situations, and rigorous valuation over passive optimism. The episode frames active risk assessment as essential across equities, insurance, real estate, and macro bets.

🔓 Sign Up for Unlimited Episode Search

About We Study Billionaires

We interview and study famous financial billionaires, including Warren Buffett, Ray Dalio, and Howard Marks, and teach you what we learn and how you can apply their investment strategies in the stock market. We Study Billionaires is the largest stock investing podcast show in the world with 180,000,000+ downloads and is hosted by Stig Brodersen, Preston Pysh, William Green, Clay Finck, and Kyle Grieve. This podcast also includes the Richer Wiser Happier series hosted by best-selling author Wi...

View all episodes from We Study Billionaires